Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC

BACKGROUND: Immunotherapy has become increasingly important in the perioperative period of non-small-cell lung cancer (NSCLC). In this study, we intended to develop a mutation-based model to predict the therapeutic effificacy of immune checkpoint inhibitors (ICIs) in patients with NSCLC. METHODS: Ra...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ping, Liu, Jie, Xu, Qingyuan, Ma, Huaijun, Niu, Beifang, Huang, Gang, Wu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998990/
https://www.ncbi.nlm.nih.gov/pubmed/36910641
http://dx.doi.org/10.3389/fonc.2023.1089179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998990/
https://www.ncbi.nlm.nih.gov/pubmed/36910641
http://dx.doi.org/10.3389/fonc.2023.1089179

Ejemplares similares